Friday - April 4, 2025
Agilent PD-L1 IHC 28-8 PharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-Small Cell Lung Cancer and Melanoma Indications
March 11, 2025
SANTA CLARA, California, March 11 -- Agilent Technologies, a company that specializes in life sciences, diagnostics and applied chemical markets, issued the following news release on March 10, 2025:

* * *

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications

Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new com . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products